Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

BACKGROUND: It remains uncertain if prior use of oral anticoagulants (OACs) in COVID-19 outpatients with multimorbidity impacts prognosis, especially if cardiometabolic diseases are present. Clinical outcomes 30-days after COVID-19 diagnosis were compared between outpatients with cardiometabolic dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Caravaca, José Miguel, Harrison, Stephanie L., Buckley, Benjamin J. R., Fazio-Eynullayeva, Elnara, Underhill, Paula, Marín, Francisco, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417638/
https://www.ncbi.nlm.nih.gov/pubmed/34481513
http://dx.doi.org/10.1186/s12933-021-01368-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417638/
https://www.ncbi.nlm.nih.gov/pubmed/34481513
http://dx.doi.org/10.1186/s12933-021-01368-6

Ejemplares similares